PMDA drug package insert
ベタナミン錠10mg
PMDA Prescription drug · 株式会社三和化学研究所 · package insert Aug 28, 2020
Key facts
| Brand names | ベタナミン錠10mg, ベタナミン錠25mg, ベタナミン錠50mg |
|---|---|
| Nonproprietary names | ペモリン |
| Companies | 製造販売元／株式会社三和化学研究所 |
| Product type | Prescription drug |
| Therapeutic category | 精神神経用剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179023F1035, 1179023F2023, 1179023F3020 |
| Approval numbers | 21700AMX00095000, 15400AMZ00782000, 15400AMZ00783000 |
| Package insert edition | 第1版 |
| Package insert date | Aug 28, 2020 |
| PMDA document key | 300297_1179023F1035_2 |
| PMDA company code | 300297 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: